Quadrant Capital Group’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$770	Hold	281	–	–	﹤0.01%	2608
2025 Q4	$1.04K	Hold	281	–	–	﹤0.01%	2595
2025 Q3	$745	Buy	+281	New	+$543	﹤0.01%	2578
2025 Q1	–	Sell	-735	Closed	-$1.62K	–	2774
2024 Q4	$1.62K	Hold	735	–	–	﹤0.01%	2524
2024 Q3	$1.21K	Buy	735 +300	+69%	+$606	﹤0.01%	2565
2024 Q2	$966	Buy	+435	New	+$1.02K	﹤0.01%	2568
2023 Q2	–	Sell	-386	Closed	-$614	–	2714
2023 Q1	$614	Sell	386 -573	-60%	-$2.96K	﹤0.01%	2580
2022 Q4	$5.97K	Sell	959 -554	-37%	-$3.96K	﹤0.01%	2166
2022 Q3	$10K	Buy	1,513 +844	+126%	+$5.8K	﹤0.01%	1886
2022 Q2	$4K	Buy	669 +549	+458%	+$3.11K	﹤0.01%	2027
2022 Q1	$1K	Buy	120 +13	+12%	+$56	﹤0.01%	2289
2021 Q4	$1K	Buy	+107	New	+$857	﹤0.01%	2291
2021 Q3	–	Sell	-21	Closed	–	–	2536
2021 Q2	$0	Buy	+21	New	+$506	﹤0.01%	2446
2016 Q3	–	Sell	-377	Closed	-$3K	–	2016
2016 Q2	$3K	Buy	+377	New	+$6.25K	﹤0.01%	1336